Mst Continus (Morphine Sulfate)

Morphine sulfate, the active ingredient in Mst Continus, is an opioid analgesic presented as an oral formulation for oral use. It provides analgesia for moderate to severe acute pain, postoperative pain, and cancer‑related pain.

GNH USA supplies Mst Continus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mst Continus, an opioid analgesic, acts on the mu‑opioid receptor pathway to relieve pain.

- Moderate to severe acute pain: provides effective analgesia for short‑term severe pain episodes. - Post‑operative pain: manages pain following surgical procedures. - Cancer‑related pain: alleviates chronic pain associated with malignancy.

Mst Continus may cause a range of adverse reactions.

Common Side Effects: - Nausea - Constipation - Drowsiness - Dizziness - Dry mouth - Sweating

Serious or Rare Side Effects: - Respiratory depression - Severe hypotension - Adrenal insufficiency - Serotonin syndrome - Anaphylactic reaction - Dependence or addiction

Before prescribing Mst Continus, clinicians should consider several safety measures.

- Assess pain severity: confirm that opioid therapy is appropriate for the level of pain. - Evaluate respiratory function: monitor patients with compromised breathing. - Review medication history: identify concurrent CNS depressants. - Monitor for signs of dependence: watch for misuse or addiction. - Adjust dose in renal/hepatic impairment: consider reduced clearance. - Store at room temperature: keep in the original pack, protect from moisture.

Mst Continus can interact with other medicines; awareness of the interaction level is essential.

Major Interactions (Avoid): - CNS depressants (e.g., benzodiazepines, barbiturates): may cause profound sedation and respiratory depression. - MAO inhibitors: increase risk of serotonin syndrome. - Alcohol: enhances central nervous system depression.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole): may raise morphine plasma levels. - Diuretics: can exacerbate hypotension. - Antidepressants (e.g., SSRIs): may increase serotonin syndrome risk.